US 12385010
Gene therapy for recessive dystrophic epidermolysis bullosa using genetically corrected autologous keratinocytes
granted A61KA61K48/0058A61K48/0075
Quick answer
US patent 12385010 (Gene therapy for recessive dystrophic epidermolysis bullosa using genetically corrected autologous keratinocytes) held by United States Government as represented by the Department of Veterans Affairs expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- United States Government as represented by the Department of Veterans Affairs
- Grant date
- Tue Aug 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K48/0058, A61K48/0075, A61K48/0091, A61P